PHARMA - September 2020
Learning Objectives
- Gain an understanding of the appropriate collaborative care and referral of patients with cataract
- Become more familiar with the clinical dilemmas associated with low-dose atropine for myopia control
- Improve knowledge on the Black Triangle Scheme and the intentions behind its development
- Better understand how low blood pressure and obstructive sleep apnoea can increase risk of development of glaucoma
- Become more familiar with the therapeutic medication prescribing patterns of Australian optometrists
- Improve knowledge on retinal changes associated with COVID-19 as detected by OCT
- Become more familiar with the presence of reticular pseudodrusen in AMD
- Gain a better understanding of the prevalence of and techniques used in the detection of diabetic retinopathy
- Become more familiar with how best to diagnose glaucoma progression with the use of OCT
- Gain a better understanding of the resources available to detect and manage dry eye disease, including the use of topical steroids
- Become more familiar with adenoviral conjunctivitis and the therapeutic medication management required to appropriately manage this
Max CPD hours awarded: 4.5
Session Information
Name |
---|
PHARMA - September 2020 |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
3 |
Duration of CPD Session/Module inclusive of Assessment Component |
4.5 |